Table 1.
Etiology | Mechanism | |
---|---|---|
Exogenous | Iatrogenic | Exogenous administration of supraphysiologic doses of glucocorticoids as part of therapeutic scheme for a medical condition (autoimmune, rheumatologic, malignant etc) |
Endogenous | ACTH-dependent | Pituitary ACTH secreting tumors (ACTH-secreting pituitary adenomas or carcinomas, pituitary blastomas) |
Ectopic ACTH and/or CRH secretion (bronchial, thymic, or pancreatic neuroendocrine tumors, and others) | ||
ACTH-independent | Adrenocortical carcinomas | |
Cortisol-Producing Adrenocortical adenomas (CPAs) | ||
Bilateral adrenocortical hyperplasia (BAH) - Micronodular (most nodules < 1cm) • Pigmented • Primary Pigmented Nodular Adrenocortical Disease (PPNAD) in the context of Carney complex • Isolated Primary Pigmented Nodular Adrenocortical Disease (PPNAD) • Isolated Micronodular Adrenocortical Disease (iMAD) - Macronodular (most nodules > 1cm) • Bilateral Macroadenomatous hyperplasia (BMAH): adenomas with internodular atrophy • Massive Macronodular Adrenocortical Disease (MMAD): adenomas with internodular hyperplasia |